Related content

Paul S. Viviano, President and Chief Executive Officer of Children’s Hospital Los Angeles; Alan S. Wayne, MD, Director of the Cancer and Blood Disease Institute at CHLA; and Lara Khouri, MBA, MPH, Executive Vice President and Chief Operating Officer of CHLA, at the grand opening of the cGMP Laboratory

New cGMP Facility Aims to Accelerate Cell Therapy for Pediatric Cancer

May 12, 2023

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

Computer illustration of CAR (chimeric antigen receptor) T cell immunotherapy, a process that is being developed to treat cancer

Research and Breakthroughs

5 Things to Know About Advances in Cancer Research

July 3, 2023

Dramatic advances in cancer research and treatment over the past two decades have made it possible for more children to survive a cancer diagnosis.

Press Release

Children’s Hospital Los Angeles Names James F. Amatruda, MD, PhD, as Director of the Cancer and Blood Disease Institute

August 13, 2024

LOS ANGELES (August 13, 2024) – Children’s Hospital Los Angeles has named James F. Amatruda, MD, PhD, a highly respected medical leader, clinician, and researcher with global recognitions, as Director

Research and Breakthroughs

Creating an Atlas to Map the Progression of Rare Childhood Cancers

October 1, 2024

CHLA researchers receive NIH grant to build Pediatric Solid Tumor Microenvironment Atlas for Wilm’s Tumor, Neuroblastoma and Rhabdomyosarcoma

Press Release

Children’s Hospital Los Angeles and USC Announce the Creation of a $40 Million Collaboration for Pediatric Biomedical Research and Innovation

April 4, 2023

The Initiative Will Benefit Innovative Studies and Projects Focused on Improving Children’s Health

Research and Breakthroughs

Team Aims to Transform Care for Diffuse Intrinsic Pontine Glioma

February 15, 2023

Two federal grants are supporting efforts at Children’s Hospital Los Angeles to develop novel therapies for this aggressive childhood brain tumor.

Press Release

CHLA Researcher to Lead First-Ever International Liquid Biopsy Retinoblastoma Study

August 1, 2023

Study will investigate the use of liquid biopsy for diagnosis and determining disease severity.

A woman with medium skin tone and long brown hair wearing a dark blouse under a white lab coat smiles as they sit at an office desk with Los Angeles visible through the large windows in the background

Press Release

Children’s Hospital Los Angeles Neurologist Honored With Prestigious Research Award

March 4, 2024

Children’s Hospital Los Angeles neurologist Shafali Spurling Jeste, MD, received the 2024 Martha Bridge Denckla Award from the Child Neurology Society.

Peter Chiarelli, MD, DPhil and other surgeons at an operating table

Research and Breakthroughs

Can a Tiny Particle Make a Big Impact on Diffuse Intrinsic Pontine Glioma?

June 5, 2023

Investigators are exploring a novel use for nanoparticles: enhancing radiation therapy for an aggressive childhood brain tumor.

Content related to Children’s Hospital Los Angeles Awarded $6 Million from CIRM to Advance CAR T-Cell Therapies in Recurring Solid Tumors in Children

Stay Up to Date